Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Alaunos Therapeutics (TCRT) Restructuring Costs (2023)

Historic Restructuring Costs for Alaunos Therapeutics (TCRT) over the last 1 years, with Q4 2023 value amounting to $850000.0.

  • Alaunos Therapeutics' Restructuring Costs changed N/A to $850000.0 in Q4 2023 from the same period last year, while for Dec 2024 it was $1.3 million, marking a year-over-year change of 0.0%. This contributed to the annual value of $1.3 million for FY2023, which is N/A changed from last year.
  • Latest data reveals that Alaunos Therapeutics reported Restructuring Costs of $850000.0 as of Q4 2023.
  • Over the past 5 years, Alaunos Therapeutics' Restructuring Costs peaked at $850000.0 during Q4 2023, and registered a low of $419000.0 during Q3 2023.